PARP3 and breast cancer: Based on the Human Protein Atlas datasets, GLUL and PARP3 were genes associated with favorable prognosis in BC using the best cutoff separation, which divides the patients into two groups with 91%/86% 5-year survival for patients with high expression versus 79%/72% for patients with low expression, respectively (p < 0.001, Figure 9E,F).